Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in TXMD held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | Rubric Capital Management LP | 1.2M | $2.4M | 0.0% | 10.300% | 0.03% |
| 2 | Clearline Capital LP | 635K | $1.3M | 0.0% | 5.488% | 0.10% |
| 3 | Squadron Capital Management LLC | 420K | $849K | β | 3.632% | 0.35% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 354K | $714K | β | 3.056% | 0.00% |
| 5 | Tejara Capital Ltd | 346K | $699K | -1.4% | 2.988% | 0.23% |
| 6 | ADAR1 Capital Management, LLC | 209K | $423K | 0.0% | 1.808% | 0.03% |
| 7 | RENAISSANCE TECHNOLOGIES LLC | 146K | $295K | +51.5% | 1.263% | 0.00% |
| 8 | MORGAN STANLEY | 129K | $261K | 0.0% | 1.116% | 0.00% |
| 9 | BlackRock, Inc. | 115K | $233K | -0.9% | 0.995% | 0.00% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 110K | $222K | +3.5% | 0.949% | 0.00% |
| 11 | VANGUARD FIDUCIARY TRUST CO | 64K | $129K | β | 0.551% | 0.00% |
| 12 | STATE STREET CORP | 30K | $61K | 0.0% | 0.260% | 0.00% |
| 13 | XTX Topco Ltd | 27K | $56K | β | 0.237% | 0.00% |
| 14 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 21K | $43K | -64.2% | 0.183% | 0.00% |
| 15 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 17K | $34K | 0.0% | 0.147% | 0.00% |
| 16 | NORTHERN TRUST CORP | 16K | $33K | -2.2% | 0.139% | 0.00% |
| 17 | DIMENSIONAL FUND ADVISORS LP | 11K | $22K | β | 0.092% | 0.00% |
| 18 | Vanguard Global Advisers, LLC | 5K | $10K | β | 0.043% | 0.00% |
| 19 | Tower Research Capital LLC (TRC) | 2K | $3K | -38.9% | 0.013% | 0.00% |
| 20 | EverSource Wealth Advisors, LLC | 141 | $1K | +14000.0% | 0.001% | 0.00% |
| 21 | NATIONAL BANK OF CANADA /FI/ | 610 | $1K | 0.0% | 0.005% | 0.00% |
| 22 | Smartleaf Asset Management LLC | 601 | $1K | 0.0% | 0.005% | 0.00% |
| 23 | UBS Group AG | 331 | $669 | -70.3% | 0.003% | 0.00% |
| 24 | SBI Securities Co., Ltd. | 267 | $539 | +4.7% | 0.002% | 0.00% |
| 25 | US BANCORP \DE\ | 246 | $497 | 0.0% | 0.002% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in TXMD β a direct measure of their conviction.
Filings activity in TXMD during Q1 2026, grouped by how each filer changed its position.
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 47 | +9.3% | 30.57% | +8.93 pp | $8M | +41% |
| Q4 2025 | 43 | 4.4% | 21.64% | +7.73 pp | $6M | +56% |
| Q3 2025 | 45 | +7.1% | 13.91% | 0.92 pp | $4M | 6.2% |
| Q2 2025 | 42 | +0.0% | 14.83% | +2.68 pp | $4M | +22% |
| Q1 2025 | 42 | +5.0% | 12.15% | +0.72 pp | $3M | +6.3% |
| Q4 2024 | 40 | +11% | 11.43% | 10.60 pp | $3M | 48% |
| Q3 2024 | 36 | 2.7% | 22.03% | +0.49 pp | $6M | +2.3% |
| Q2 2024 | 37 | β | 21.54% | β | $5M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying TXMD stock.
Based on Q1 2026 13F filings, institutional ownership of TherapeuticsMD, Inc. stands at 30.6%, held across 47 reporting institutions.
Rubric Capital Management LP is the largest reported institutional holder of TXMD, with approximately 1,192,191 shares worth $0.00B as of Q1 2026.
Yes β 2 widely-followed marquee investors appear among the top 25 institutional holders of TXMD, including RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP.
Our composite Smart Money Score for TXMD is 69 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
10 institutions opened new positions in TXMD during Q1 2026, while 6 fully exited. 28 added to existing positions and 6 trimmed.
TXMD institutional ownership rose by 8.93 percentage points quarter-over-quarter, with a net change of +4 holders.
The top 10 institutions account for 94.9% of all reported 13F value in TXMD, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
TherapeuticsMD, Inc. (TXMD) Institutional Ownership